Małgorzata Wamil

ORCID: 0000-0002-5361-2532
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hormonal Regulation and Hypertension
  • Cardiovascular Function and Risk Factors
  • Blood Pressure and Hypertension Studies
  • Infective Endocarditis Diagnosis and Management
  • Cardiac Imaging and Diagnostics
  • Long-Term Effects of COVID-19
  • Cardiac Valve Diseases and Treatments
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Heart Rate Variability and Autonomic Control
  • Steroid Chemistry and Biochemistry
  • Cardiovascular Disease and Adiposity
  • Infectious Encephalopathies and Encephalitis
  • Cardiovascular Health and Disease Prevention
  • Cholesterol and Lipid Metabolism
  • Thermal Regulation in Medicine
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Adrenal Hormones and Disorders
  • Immune Response and Inflammation
  • Receptor Mechanisms and Signaling
  • Clusterin in disease pathology
  • Synthesis and biological activity
  • Apelin-related biomedical research
  • Bioactive natural compounds

University of Oxford
2012-2024

Great Western Hospital
2021-2024

London Clinic
2024

Great Western Hospitals NHS Foundation Trust
2020-2023

Oxford University Hospitals NHS Trust
2017-2023

University College London
2022

Martin University
2021

Oxford Centre for Diabetes, Endocrinology and Metabolism
2019-2021

GW4
2020

John Radcliffe Hospital
2019

Objective To assess medium-term organ impairment in symptomatic individuals following recovery from acute SARS-CoV-2 infection. Design Baseline findings a prospective, observational cohort study. Setting Community-based two UK centres between 1 April and 14 September 2020. Participants Individuals ≥18 years with persistent symptoms infection age-matched healthy controls. Intervention Assessment of by standardised questionnaires (EQ-5D-5L, Dyspnoea-12) organ-specific metrics biochemical...

10.1136/bmjopen-2020-048391 article EN cc-by BMJ Open 2021-03-01
Kazem Rahimi Zeinab Bidel Milad Nazarzadeh Emma Copland Dexter Canoy and 95 more Małgorzata Wamil Jeannette Majert Richard J. McManus Amanda Adler Larry Agodoa Ale Algra Folkert W. Asselbergs Nigel Beckett Eivind Berge Henry R. Black Eric Boersma Frank P. Brouwers Morris J. Brown Jasper J. Brugts Christopher J. Bulpitt Robert P. Byington William C. Cushman Jeffrey A. Cutler Richard B. Devereaux Jamie P. Dwyer Ray Estacio Robert Fagard Keith A.A. Fox Tsuguya Fukui Ajay Gupta Rury R. Holman Yutaka Imai Masao Ishii Stevo Julius Yoshihiko Kanno Sverre E. Kjeldsen John B. Kostis Kizuku Kuramoto Jan Lanke Edmund J. Lewis Julia B. Lewis Michel Lièvre Lars Lindholm Stephan Lueders Stephen MacMahon Giuseppe Mancia Masunori Matsuzaki Maria H. Mehlum Steven Nissen Hiroshi Ogawa Toshio Ogihara Takayoshi Ohkubo Christopher R. Palmer Anushka Patel Marc Allan Pfeffer Bertram Pitt Neil R Poulter Hiromi Rakugi Gianpaolo Reboldi Christopher M. Reid Giuseppe Remuzzi Piero Ruggenenti Takao Saruta Joachim Schrader Robert W. Schrier Peter Sever Peter Sleight Jan A. Staessen Hiromichi Suzuki Lutgarde Thijs Kenji Ueshima Seiji Umemoto Wiek H. van Gilst Paolo Verdecchia Kristian Wachtell Paul K. Whelton Lindon Wing Mark Woodward Yoshiki Yui Salim Yusuf Alberto Zanchetti Zhen‐Yu Zhang Craig S. Anderson Colin Baigent Barry M. Brenner Rory Collins Dick de Zeeuw Jacobus Lubsen Ettore Malacco Bruce Neal Vlado Perkovic Anthony Rodgers Peter M. Rothwell Gholamreza Salimi-Khorshidi Johan Sundström Fiona Turnbull Giancarlo Viberti Ji‐Guang Wang John Chalmers Barry R. Davis

BackgroundThe effects of pharmacological blood-pressure-lowering on cardiovascular outcomes in individuals aged 70 years and older, particularly when blood pressure is not substantially increased, uncertain. We compared the treatment risk major events groups patients stratified by age at baseline.MethodsWe did a meta-analysis using individual participant-level data from randomised controlled trials versus placebo or other classes medications, between more less intensive strategies, which had...

10.1016/s0140-6736(21)01921-8 article EN cc-by The Lancet 2021-08-27

Nicotinic acid (NA) treatment has been associated with benefits in atherosclerosis that are usually attributed to effects on plasma lipoproteins. The NA receptor GPR109A is expressed monocytes and macrophages, suggesting a possible additional role for modulating function of these immune cells. We hypothesize the potential act directly alter mediators inflammation may contribute its antiatherogenic vivo.In human activated by Toll-like (TLR)-4 agonist lipopolysaccharide, reduced secretion...

10.1161/atvbaha.111.241836 article EN Arteriosclerosis Thrombosis and Vascular Biology 2012-01-21

Abstract Background Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection has disproportionately affected older individuals and those with underlying medical conditions. Research focused on short-term outcomes in hospital, single organ involvement. Consequently, impact of long COVID (persistent symptoms three months post-infection) across multiple organs low-risk is yet to be assessed. Methods An ongoing prospective, longitudinal, two-centre, observational study was...

10.1101/2020.10.14.20212555 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-10-16

Background Long COVID is associated with multiple symptoms and impairment in organs. Cross-sectional studies have reported cardiac to varying degrees by methodologies. Using MR (CMR), we investigated a 12-month trajectory of abnormalities COVID. Objectives To investigate 1-year post-SARS-CoV-2 infection. Methods 534 individuals underwent CMR (T1/T2 mapping, mass, volumes, function strain) multiorgan MRI at 6 months (IQR 4.3–7.3) since first post-COVID-19 symptoms. 330 were rescanned 12.6...

10.1136/openhrt-2022-002241 article EN cc-by Open Heart 2023-02-01

Insulin resistance (IR) may mediate heart failure (HF) development. We examined whether IR in people with newly diagnosed type 2 diabetes (T2D) increased their risk of a composite outcome HF or death alone.Insulin (HOMA2-IR) values for UKPDS participants were derived from paired fasting plasma glucose (FPG) and insulin measures. Kaplan-Meier survival curves multivariable models used to evaluate associations between HOMA2-IR HF/death alone. adjusted potential confounders by including...

10.2337/dc21-0429 article EN Diabetes Care 2021-06-23

The study objective was to determine the key early mechanisms underlying beneficial redistribution, function, and inflammatory profile of adipose tissue in 11β-hydroxysteroid dehydrogenase type 1 knockout (11β-HSD1(-/-)) mice fed a high-fat (HF) diet.

10.2337/db10-0830 article EN cc-by-nc-nd Diabetes 2011-02-25

Despite major advances in understanding monogenic causes of morbid obesity, the complex genetic and environmental etiology idiopathic metabolic syndrome remains poorly understood. One hypothesis suggests that similarities between disease plasma glucocorticoid excess (Cushing’s syndrome) results from increased reamplification within adipose tissue by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1). Indeed, 11β-HSD-1 is now a therapeutic target. Because much supporting evidence for role...

10.2337/diabetes.54.12.3371 article EN Diabetes 2005-12-01

Obesity is associated with an increased risk of diabetes type 2, dyslipidemia, and atherosclerosis. These cardiovascular metabolic abnormalities are exacerbated by excessive dietary fat, particularly cholesterol its metabolites. High adipose tissue glucocorticoid levels, generated the intracellular enzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1), also implicated in pathogenesis obesity, syndrome, 11β-HSD1 interconverts atherogenic oxysterols 7-ketocholesterol (7KC) 7β-hydroxycholesterol...

10.1210/en.2008-0420 article EN Endocrinology 2008-08-28

Early risk stratification after ST-segment-elevation myocardial infarction (STEMI) is of major clinical importance. Strain quantifies deformation and can demonstrate abnormal global segmental function in acute ischaemia. Native T1-mapping allows assessment the severity ischemic injury, however its applicability early post MI limited by complex dynamic changes happening myocardium MI. We aimed to explore relationship between feature tracking imaging, establish whether combined analysis these...

10.1007/s10554-019-01542-8 article EN cc-by The International Journal of Cardiovascular Imaging 2019-02-16

Abstract Background Long Covid is associated with multiple symptoms and impairment in organs [1]. Cardiac has been reported to varying degrees by methodologies cross-sectional studies. Using cardiovascular magnetic resonance (CMR), we investigated the 12-month trajectory of cardiac individuals Covid. Purpose We conducted a prospective, longitudinal, 1-year study investigate 1) characteristics impairment; 2) impact acute hospitalisation for COVID-19 on 3) pathways designing improving clinical...

10.1093/eurheartj/ehac544.219 article EN European Heart Journal 2022-10-01

Severe aortic stenosis is a major cause of morbidity and mortality. The existing treatment pathway for transcatheter valve implantation (TAVI) traditionally relies on tertiary Heart Valve Centre workup. However, this has been associated with delays to treatment, in breach British Cardiovascular Intervention Society targets. A novel emphasis comprehensive patient workup at local centre, alongside close collaboration Centre, may help reduce the time TAVI.The centre performing implemented TAVI...

10.1136/openhrt-2022-002170 article EN cc-by-nc Open Heart 2023-09-01

Abstract Diabetes is a heterogenous, multimorbid disorder with large variation in manifestations, trajectories, and outcomes. The aim of this study to validate novel machine learning method for the phenotyping diabetes context comorbidities. Data from 9967 patients new diagnosis were extracted Clinical Practice Research Datalink. First, using BEHRT (a transformer-based deep architecture), embeddings corresponding learned. Next, topological data analysis (TDA) was carried out test how...

10.1038/s41598-023-38251-1 article EN cc-by Scientific Reports 2023-07-16

Abstract Background Long Covid is associated with multiple symptoms and impairment in organs. Cardiac has been reported to varying degrees by methodologies cross-sectional studies. Using cardiac magnetic resonance (CMR), we investigated the 12-month trajectory of individuals Covid. Methods 534 underwent baseline CMR (T1 T2 mapping, mass, volumes, function, strain) multi-organ MRI at 6 months (IQR 4.3,7.3) since first post-COVID-19 330 were rescanned 12.6 11.4, 14.2) if abnormal findings...

10.1101/2022.04.03.22272610 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2022-04-04
Coming Soon ...